Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

CRANFORD, N.J., July 10, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced expected milestones in the second half of calendar 2024 and recapped key achievements year-to-date Citius significantly advanced its two late-stage product candidates in the first six months of 2024, and expects several key milestones in the nea ...